Le Lézard
Classified in: Science and technology, Covid-19 virus
Subject: Product/Service

F5 Unveils NGINX for Microsoft Azure to Deliver Secure, High-Performance Applications for the Azure Ecosystem


F5 (NASDAQ: FFIV) today announced the release of F5 NGINX for Microsoft Azure, an Azure-native service offering developed in partnership with Microsoft, that helps customers deliver modern applications on Azure with just a few clicks. With NGINX for Azure, developers can lift and shift on-premises applications to Azure and deploy new, born-in-the-cloud services using NGINX, the familiar and trusted load balancing solution.

According to F5's 2022 State of Application Strategy Report, the COVID-19 pandemic has accelerated cloud migration?with three-quarters of organizations deploying applications in public cloud environments. With increasing cloud adoption, more than 25% of organizations also host application security and delivery services in the cloud. Developers, cloud architects, system architects, and other practitioners who want to run their applications on Azure need an easy migration path to the cloud, fast and continuous delivery of secure digital services at scale, and consistency in application performance between on-premises and cloud environments.

NGINX for Azure addresses these needs by enabling enterprises to:

By using the same load balancing solution across their estate of applications on-premises and on Azure, enterprises achieve consistency in performance and security, resulting in a superior digital experience for their customers.

"NGINX powers the world's busiest websites with a suite of advanced connectivity, traffic management, and security solutions?all of which bring additional value to the Microsoft Azure ecosystem," said Eric Braun, Vice President, NGINX Product Management, F5. "The combination of Microsoft's trusted cloud and NGINX's trusted software offered as a service on Azure enables developers and DevOps teams to optimize the performance, reliability, and security of their distributed applications and services at a global scale."

"Development teams are constantly pushing the envelope as they innovate. Getting up and running on any project in minutes with a fully configured, secure, cloud-hosted environment empowers teams to achieve the goals of their business faster," said Julia Liuson, President of the Developer Division, Microsoft. "Our collaboration with F5 will make it easier for application developers, IT operators, and service operation teams to respond more quickly to their customers by providing NGINX networking capabilities integrated natively into Microsoft Azure so they can deliver their applications with improved performance, reliability, and security."

NGINX for Azure is now available for public preview in the Azure Marketplace.

Additional Resources

About F5

F5 (NASDAQ: FFIV) is a multi-cloud application security and delivery company that enables our customers?which include the world's largest enterprises, financial institutions, service providers, and governments?to bring extraordinary digital experiences to life. For more information, go to f5.com. You can also follow @F5 on Twitter or visit us on LinkedIn and Facebook for more information about F5, its partners, and technologies.

F5 is a trademark, service mark, or tradename of F5, Inc., in the U.S. and other countries. All other product and company names herein may be trademarks of their respective owners.

Source: F5, Inc.


These press releases may also interest you

at 07:05
Aurora Labs, founded in 2016 by Zohar Fox (CEO) and Ori Lederman (COO), announced today that it has secured $63 million through a Series C financing round led by Moore Strategic Ventures ("MSV"). Also participating in the round was existing investor...

at 07:05
Tebra, the digital backbone for independent healthcare practices, today announced that it has closed more than $72 million in funding at a valuation greater than $1 billion. Golub Capital led the investment which includes both growth equity and debt...

at 07:05
Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, announced today that the first patient was treated at the David C. Pratt Cancer Center at Mercy Hospital St. Louis on...

at 07:05
Vedanta Biosciences, a clinical-stage biopharmaceutical company pioneering the development of oral therapies based on defined bacterial consortia, today announced that members of its executive team will participate at the following investor...

at 07:05
The USA has been ranked as one of the cheapest and fastest countries among 170 jurisdictions worldwide for incorporating and managing the USA-based entities of multinationals, according to data compiled by the entity portfolio management (EPM) leader...

at 07:05
Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the grant of stock options to purchase 120,500 shares of its common stock and the grant of 80,400 restricted stock units...



News published on 24 may 2022 at 07:05 and distributed by: